Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

south yarra pharma pty ltd - bismuth subnitrate - unknown - bismuth subnitrate mineral-bismuth active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - bismuth subnitrate - unknown - bismuth subnitrate mineral-bismuth active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imaginus limited - bismuth subnitrate - unknown - bismuth subnitrate mineral-bismuth active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetsense pty ltd - bismuth subsalicylate - unknown - bismuth subsalicylate mineral-bismuth active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - bismuth subnitrate - unknown - bismuth subnitrate mineral-bismuth active 0.0 - active constituent

Canada - English - Health Canada

laboratoires juvise pharmaceuticals - bismuth oxide (bismuth subcitrate potassium); tetracycline hydrochloride; metronidazole - capsule - 40mg; 125mg; 125mg - bismuth oxide (bismuth subcitrate potassium) 40mg; tetracycline hydrochloride 125mg; metronidazole 125mg - tetracyclines

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - bismuth subgallate 100% - powder for oral solution - 100 % - active: bismuth subgallate 100%

Ireland - English - HPRA (Health Products Regulatory Authority)

mcneil healthcare (ireland) ltd - hydrocortisone acetate, benzyl benzoate, bismuth subgallate, bismuth oxide, balsam peru, zinc oxide - ointment - n/a - corticosteroids, weak, comb with antiseptics

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth - unii:u015tt5i8h), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium 140 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of pylera and other antibacterial drugs, pylera should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. pylera in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. do not administer methoxyflurane to patients taking pylera. the concurrent use of tetracycline hydrochloride, a component of pylera, with methoxyflurane has been reported to resu

Ireland - English - HPRA (Health Products Regulatory Authority)

sofibel - hydrocortisone acetate; benzyl benzoate; bismuth subgallate; bismuth oxide; balsam peru; zinc oxide - ointment - 0.25/1.25/2.25/0.875/1.875/10.75 gram/100gram - corticosteroids, weak, combinations with antiseptics